Evercore ISI analyst Elizabeth Anderson lowered the firm’s price target on Dentsply Sirona (XRAY) to $13 from $15 and keeps an In Line rating on the shares. The firm made several price target adjustments and additions to the firm’s Tactical call lists as part of the firm’s healthcare technology and distribution preview for Q1.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on XRAY:
- Reaffirming Hold: Updated Earnings Outlook and Interest Assumptions Support Fair Valuation
- Dentsply Sirona, Siemens Healthineers share findings from trial of MRI system
- Dentsply Sirona price target raised to $18 from $16 at UBS
- Dentsply Sirona price target raised to $17 from $14 at Barrington
- Dentsply Sirona price target raised to $16 from $14 at Mizuho